Form 4: LivaNova PLC Director James Christopher Barry Acquires Restricted Stock Units

Director James Christopher Barry acquired 3,416 Restricted Stock Units (RSUs) of LivaNova PLC on June 15, 2024, which will vest on June 15, 2025.

Summary

• On June 15, 2024, James Christopher Barry, a director of LivaNova PLC, acquired 3,416 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one ordinary share of LivaNova PLC.
• The RSUs will vest on June 15, 2025, contingent upon continued service during the vesting period and adherence to the award agreement.
• The transaction was reported on June 18, 2024.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (RSU grant) which is generally viewed neutrally to positively as it aligns director interests with shareholders. There are no red flags or negative implications.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The RSUs vest on June 15, 2025, subject to continued service, indicating a long-term incentive for the director.

Industry Context

This is a standard practice for aligning the interests of company directors with those of shareholders through equity-based compensation.

Comparison to Industry Standards

• Granting restricted stock units to directors is a common practice among publicly traded companies to incentivize performance and align interests with shareholders.
• Companies like Medtronic and Boston Scientific also use similar equity-based compensation plans for their executives and directors.
• The vesting period of one year is fairly standard, as longer vesting periods are also common to ensure long-term commitment.

Stakeholder Impact

• The RSU grant aligns the director's interests with those of the shareholders, incentivizing them to work towards increasing shareholder value.

Key Dates